Patents by Inventor Henry Zhu

Henry Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240134876
    Abstract: Computer implemented systems and methods are disclosed for importing data from electronic data files. In accordance with some embodiments, a file format is assigned to a source electronic data files by a data importation system. The data importation system may further identify a file type identifier associated with the source electronic data file and map the source electronic data file to a transformation template. The data importation system may further store the file format, file type identifier, and an indication of the transformation template as a file type profile associated with the source electronic data file in a database.
    Type: Application
    Filed: October 25, 2023
    Publication date: April 25, 2024
    Inventors: Stephen Yazicioglu, Christopher Luck, Robert Giardina, Justin Streufert, Timothy Slatcher, Gregory O'Connor, Brandon Marc-Aurele, Olivia Zhu, Howard Schindel, Henry Tung, Lucas Ray, Christopher Leech, Eric Jeney, Stefan Negrus, Jason Lee, Alessandro Mingione, John McKinstry Doyle, Hunter Pitelka, Ethan Lozano, Joel Ossher, Matthew Fedderly
  • Patent number: 10759859
    Abstract: A subset of humanized anti-PD-1 antibodies that inhibit binding of PD-L1 and PD-L2 to human PD-1. These binding proteins modulate the immune system through the manipulation of the PD-1 signaling pathway to treat immune dysfunctional disorders, including for example cancers.
    Type: Grant
    Filed: January 14, 2017
    Date of Patent: September 1, 2020
    Assignee: BPS Bioscience, Inc.
    Inventors: Xiaohui Yuan, Aaron Snead, Zhihua Tao, Kim Skuster, Colin Cowdrey, Jonathan Mikolosko, Andrew Newman, Henry Zhu
  • Publication number: 20190016806
    Abstract: A subset of humanized anti-PD-1 antibodies that inhibit binding of PD-L1 and PD-L2 to human PD-1. These binding proteins modulate the immune system through the manipulation of the PD-1 signaling pathway to treat immune dysfunctional disorders, including for example cancers.
    Type: Application
    Filed: January 14, 2017
    Publication date: January 17, 2019
    Inventors: Xiaohui Yuan, Aaron Snead, Zhihua Tao, Kim Skuster, Colin Cowdrey, Jonathan Mikolosko, Andrew Newman, Henry Zhu